Table 5. INTERACTION – REMODELING CHANGES BY BASELINE VIABILITY & TREATMENT GROUP.

Paired Data (Winsorized for LV ED^*, LV ES^† and WM^‡)

	SEVERELY REDUCED VIABILITY < 40%					MODERATE RETAINED VIABILITY ≥ 40%
	PCI§		MED‖			PCI		MED
	(N = 13)		(N = 20)			(N = 42)		(N = 37)			Interaction
	n	Mean±SD	n	Mean±SD	p-value	n	Mean±SD	n	Mean±SD	p-value	p-value
LV ED Volume (ml)
			1					3
Baseline	12	153.2±52.2	7	158.8±39.9	0.75	41	108.9±36.4	5	120.0±37.4	0.19	0.75
			1					3
1 yr	12	142.6±54.1	7	152.1±44.2	0.61	41	107.2±36.9	5	120.7±37.9	0.12	0.82
			1					3
Change (1 yr-Baseline)	12	−10.7±26.1	7	−6.7±19.2	0.64	41	−1.7±30.3	5	0.74±25.3	0.71	0.90
p-value (within group)		0.18		0.17			0.72		0.86
LV ES Volume (ml)
			1					3
Baseline	12	88.4±44.8	7	100.5±36.7	0.43	41	57.2±29.5	5	59.1±30.0	0.35	0.70
			1					3
1 yr	12	82.7±48.0	7	92.8±36.2	0.52	41	52.7±27.8	5	59.1±30.0	0.34	0.80
			1					3
Change (1 yr-Baseline)	12	−5.8±22.1	7	−7.7±19.5	0.80	41	4.5±22.7	5	4.5±18.2	0.99	0.84
p-value (within group)		0.39		0.12			0.21		0.15
Ejection Fraction (%)
			1					3
Baseline	12	44.8±12.6	7	38.9±10.3	0.18	41	57.2±29.5	5	48.3±10.1	0.52	0.35
			1					3
1 yr	12	45.9±16.8	7	40.4±10.2	0.28	41	52.7±27.8	5	53.6±10.0	0.96	0.27
			1					3
Change (1 yr-Baseline)	12	1.2±8.6	7	1.5±5.9	0.89	41	4.5±22.7	5	5.3±7.6	0.32	0.68
p-value (within group)		0.65		0.30			0.21		<0.001
Wall Motion Score
			1					3
Baseline	12	23.2±7.8	7	24.6±6.5	0.60	41	49.9±10.4	5	15.6±6.8	0.71	0.81
			1					3
1 yr	12	17.7±10.4	7	19.6±8.6	0.59	41	53.5±11.3	5	10.5±7.2	0.71	0.75
			1					3
Change (1 yr-Baseline)	12	−5.5±7.7	7	−5.0±6.1	0.84	41	3.7±6.5	5	−5.1±5.8	0.96	0.89
p-value (within group)				0.003			<0.001		<0.001

^*LV ED=left ventricular end-diastolic dimension,

^†LV ES =ventricular end-systolic dimension

^‡WM=wall motion,

^§PCI=percutaneous coronary intervention,

^‖MED=medical therapy alone,